- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:06 | Kane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results | 92 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") announces today its fourth quarter and full year 2025 financial results.... ► Artikel lesen | |
| 16.04. | Kane Biotech Inc (2): Kane presents revyve data at wound care conference | 2 | Stockwatch | ||
| 17.03. | Kane Biotech Inc (2): Kane Biotech highlights data on revyve biofilm action | 2 | Stockwatch | ||
| 17.03. | Kane Biotech Inc.: Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms | 2 | GlobeNewswire (USA) | ||
| 10.03. | Kane Biotech Inc (2): Kane Biotech signs with U.S. gov't distributor | 1 | Stockwatch | ||
| 10.03. | Kane Biotech Inc.: Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership | 1 | GlobeNewswire (USA) | ||
| KANE BIOTECH Aktie jetzt für 0€ handeln | |||||
| 20.02. | Kane Biotech Inc (2): Kane publishes article in International Wound Journal | 3 | Stockwatch | ||
| 20.02. | Kane Biotech Inc.: Kane Biotech Announces Publication of revyve Wound Gel Article in the International Wound Journal | 1 | GlobeNewswire (USA) | ||
| 19.02. | Kane Biotech Inc (2): Kane Biotech adds U.S. distributors for revyve products | 1 | Stockwatch | ||
| 19.02. | Kane Biotech Inc.: Kane Biotech Expands Commercial Activities in the United States | 747 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech" or the "Company") today announces that it has signed non-exclusive distribution/sales agreements... ► Artikel lesen | |
| 17.02. | Kane Biotech Inc (2): Kane Biotech passes regulatory "milestones" | 1 | Stockwatch | ||
| 17.02. | Kane Biotech Inc.: Kane Biotech Announces FDA 510(k) Clearance for revyve Antimicrobial Skin and Wound Cleanser | 505 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE) ("Kane Biotech". "Kane" or the "Company") today announces two regulatory milestones that strengthen the Company's... ► Artikel lesen | |
| 12.02. | Kane Biotech Inc (2): Kane Biotech revives commercial activity for revyve gel | 1 | Stockwatch | ||
| 12.02. | Kane Biotech Inc.: Kane Biotech Restarts Commercial Activities and Strengthens North American Management | 389 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces the resumption of commercial activities in both the United... ► Artikel lesen | |
| 30.12.25 | Kane Biotech Inc (2): Kane Biotech 14-million-share private placement | 2 | Stockwatch | ||
| 18.12.25 | Kane Biotech Inc.: Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company | 1 | GlobeNewswire (USA) | ||
| 17.12.25 | Kane Biotech Inc.: Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 10.12.25 | Kane Biotech Inc.: Kane Biotech Receives Health Canada Approval for revyve Antimicrobial Wound Gel Spray | 1 | GlobeNewswire (USA) | ||
| 28.11.25 | Kane Biotech Inc (2): Kane Biotech loses $607,345 in Q3 2025 | 1 | Stockwatch | ||
| 28.11.25 | Kane Biotech Inc.: Kane Biotech Announces Third Quarter 2025 Financial Results | 753 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announced its third quarter 2025 financial results. Third Quarter... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAION | 0,086 | +34,65 % | PAION AG: Schwächesignal im Fokus der Analyse | ||
| NANOREPRO | 1,575 | +1,94 % | From tests to brands, revamping NanoRepro; INITIATE with BUY: NanoRepro transforms into a multi-brand ... | No longer a mere self-test company, NanoRepro has used the pandemic windfall from COVID tests and transformed itself into a multi-brand consumer health platform. The company has acquired stakes in complementary... ► Artikel lesen | |
| 4SC | 0,100 | -23,37 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.12.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 16.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.12.2025ISIN NameDE000A3E5C40 4SC... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 20,470 | -8,82 % | Morning Market Movers: Super Micro Computer, Bimergen Energy, Palatin Technologies, Intellicheck See Big Swings | HONG KONG (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRAIN BIOTECH | 2,430 | -2,02 % | BRAIN BIOTECH AG - Stabilität als strategische Basis | ||
| AAP IMPLANTATE | 1,890 | +2,72 % | EQS-AFR: aap Implantate AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: aap Implantate AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
aap Implantate AG: Vorabbekanntmachung... ► Artikel lesen | |
| CO.DON | 0,015 | +3,57 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| BIOXXMED | 0,905 | 0,00 % | PTA-News: bioXXmed AG: Vollzug des Verkaufs der Rancoderm GmbH | DJ PTA-News: bioXXmed AG: Vollzug des Verkaufs der Rancoderm GmbH
Unternehmensmitteilung für den Kapitalmarkt
bioXXmed AG: Vollzug des Verkaufs der Rancoderm GmbH
Heidelberg (pta000/09.03.2026/13:50... ► Artikel lesen | |
| CLINUVEL | 5,398 | -1,17 % | Clinuvel Pharmaceuticals Limited: CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study | EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its "totality of evidence" approachcentral photographic review and validated disease... ► Artikel lesen | |
| SANGAMO THERAPEUTICS | 0,213 | -2,21 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results | Announced in June, positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across... ► Artikel lesen | |
| BIO-GATE | 0,605 | -2,42 % | EQS-News: Bio-Gate AG steigert im Geschäftsjahr 2025 den Umsatz und begrenzt den Verlust | EQS-News: Bio-Gate AG
/ Schlagwort(e): Vorläufiges Ergebnis/Jahresergebnis
Bio-Gate AG steigert im Geschäftsjahr 2025 den Umsatz und begrenzt den Verlust
20.04.2026 / 15:02... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 1,480 | -3,90 % | Cosciens Biopharma Inc: Cosciens Biopharma to exit U.S. reporting | ||
| SCORPIUS | - | - | Scorpius Holdings, Inc. - 8-K, Current Report | ||
| EDITAS MEDICINE | 2,870 | +4,36 % | Editas Medicine, Inc.: Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference | CAMBRIDGE, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today... ► Artikel lesen | |
| TREVENA | 4,000 | +1.983 % | TREVENA INC - 8-K, Current Report |
KANE BIOTECH INC gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KANE BIOTECH INC finden Sie auf Wallstreet Online.